Meyka Pro banner
Absci Corporation

Absci Corporation Fundamental Analysis (NASDAQ: ABSI)

ABSINASDAQ
HealthcareBiotechnology
$9.63
$0.79(8.94%)
U.S. Market opens in 12h 18m

Absci Corporation Fundamental Analysis (NASDAQ: ABSI)

Absci Corporation (NASDAQ: ABSI) shows weak financial fundamentals with a PE ratio of -12.06, profit margin of -77.56%, and ROE of -59.21%. The company generates $0.0B in annual revenue with weak year-over-year growth of -38.24%.

Key Strengths

Cash Position13.26%
PEG Ratio-0.72
Current Ratio10.63

Areas of Concern

ROE-59.21%
Operating Margin-84.11%
We analyze ABSI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -5885.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-5885.9/100

We analyze ABSI's fundamental strength across five key dimensions:

Efficiency Score

Weak

ABSI struggles to generate sufficient returns from assets.

ROA > 10%
-45.02%

Valuation Score

Excellent

ABSI trades at attractive valuation levels.

PE < 25
-12.06
PEG Ratio < 2
-0.72

Growth Score

Moderate

ABSI shows steady but slowing expansion.

Revenue Growth > 5%
-38.24%
EPS Growth > 10%
10.64%

Financial Health Score

Excellent

ABSI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
10.63

Profitability Score

Weak

ABSI struggles to sustain strong margins.

ROE > 15%
-5921.42%
Net Margin ≥ 15%
-77.56%
Positive Free Cash Flow
No

Key Financial Metrics

Is ABSI Expensive or Cheap?

P/E Ratio

ABSI trades at -12.06 times earnings. This suggests potential undervaluation.

-12.06

PEG Ratio

When adjusting for growth, ABSI's PEG of -0.72 indicates potential undervaluation.

-0.72

Price to Book

The market values Absci Corporation at 6.17 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.17

EV/EBITDA

Enterprise value stands at -15.81 times EBITDA. This is generally considered low.

-15.81

How Well Does ABSI Make Money?

Net Profit Margin

For every $100 in sales, Absci Corporation keeps $-77.56 as profit after all expenses.

-77.56%

Operating Margin

Core operations generate -84.11 in profit for every $100 in revenue, before interest and taxes.

-84.11%

ROE

Management delivers $-59.21 in profit for every $100 of shareholder equity.

-59.21%

ROA

Absci Corporation generates $-45.02 in profit for every $100 in assets, demonstrating efficient asset deployment.

-45.02%

Following the Money - Real Cash Generation

Operating Cash Flow

Absci Corporation generates limited operating cash flow of $-116.27M, signaling weaker underlying cash strength.

$-116.27M

Free Cash Flow

Absci Corporation generates weak or negative free cash flow of $-117.23M, restricting financial flexibility.

$-117.23M

FCF Per Share

Each share generates $-0.69 in free cash annually.

$-0.69

FCF Yield

ABSI converts -6.68% of its market value into free cash.

-6.68%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-12.06

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.72

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.17

vs 25 benchmark

P/S Ratio

Price to sales ratio

1046.68

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

10.63

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.59

vs 25 benchmark

ROA

Return on assets percentage

-0.45

vs 25 benchmark

ROCE

Return on capital employed

-0.53

vs 25 benchmark

How ABSI Stacks Against Its Sector Peers

MetricABSI ValueSector AveragePerformance
P/E Ratio-12.0632.14 Better (Cheaper)
ROE-59.21%550.00% Weak
Net Margin-7756.37%30133.00% Weak
Debt/Equity0.010.56 Strong (Low Leverage)
Current Ratio10.635.70 Strong Liquidity
ROA-45.02%3.00% Weak

ABSI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Absci Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-60.49%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-441.25%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-471.32%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ